Hanzhong Central Hospital
12
5
5
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
8.3%
1 terminated/withdrawn out of 12 trials
75.0%
-11.5% vs industry average
17%
2 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Effect of Semi-elemental Enteral Nutrition on Gastrointestinal Tolerance in Patients With Traumatic Brain Injury.
Role: collaborator
Development and Clinical Evaluation of a Novel Hollow Cusp Fracture Reducer for Femoral Shaft and Patellar Fractures
Role: lead
Establishing Reference Ranges for Fat-Soluble Vitamins in Healthy Chinese Adults
Role: collaborator
Clinical Study on the Evaluation of the Efficacy of Cervical Cancer
Role: collaborator
Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
Role: collaborator
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
Role: collaborator
Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole
Role: collaborator
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)
Role: collaborator
Predictive Model for Prognosis of Chronic HBV Infection Mothers
Role: collaborator
Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation
Role: collaborator
Controlling Hypertension After Severe Cerebrovascular Event
Role: collaborator
Efficacy of Mobile Phone Short Message Service (SMS) Reminder and Consultation on Asthma Control
Role: collaborator
All 12 trials loaded